A citation-based method for searching scientific literature

Kazumasa Miyawaki, Yuichiro Yamada, Nobuhiro Ban, Yu Ihara, Katsushi Tsukiyama, Heying Zhou, Shimpei Fujimoto, Akira Oku, Kinsuke Tsuda, Shinya Toyokuni, Hiroshi Hiai, Wataru Mizunoya, Tohru Fushiki, Jens Juul Holst, Mitsuhiro Makino, Akira Tashita, Yukari Kobara, Yoshiharu Tsubamoto, Takayoshi Jinnouchi, Takahito Jomori, Yutaka Seino. Nat Med 2002
Times Cited: 610







List of shared articles



Times cited


The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling.
Qian Zhang, Challa Tenagne Delessa, Robert Augustin, Mostafa Bakhti, Gustav Colldén, Daniel J Drucker, Annette Feuchtinger, Cristina Garcia Caceres, Gerald Grandl, Alexandra Harger,[...]. Cell Metab 2021
12

GIP receptor deletion in mice confers resistance to high-fat diet-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism.
Geke Aline Boer, Stacey N Keenan, Paula M Miotto, Jens Juul Holst, Matthew J Watt. Am J Physiol Endocrinol Metab 2021
1


Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism.
Jason A West, Anastasia Tsakmaki, Soumitra S Ghosh, David G Parkes, Rikke V Grønlund, Philip J Pedersen, David Maggs, Harith Rajagopalan, Gavin A Bewick. PLoS One 2021
1

The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update.
Michael A Nauck, Daniel R Quast, Jakob Wefers, Andreas F H Pfeiffer. Diabetes Obes Metab 2021
1

GIP's involvement in the pathophysiology of type 2 diabetes.
Mikkel B Christensen, Lærke S Gasbjerg, Sebastian M Heimbürger, Signe Stensen, Tina Vilsbøll, Filip K Knop. Peptides 2020
4

Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease.
Sebastian M Heimbürger, Natasha C Bergmann, Robert Augustin, Lærke S Gasbjerg, Mikkel B Christensen, Filip K Knop. Peptides 2020
5

Effects of Pioglitazone on Glucose-Dependent Insulinotropic Polypeptide-Mediated Insulin Secretion and Adipocyte Receptor Expression in Patients With Type 2 Diabetes.
William G Tharp, Dhananjay Gupta, Olga Sideleva, Carolyn F Deacon, Jens J Holst, Dariush Elahi, Richard E Pratley. Diabetes 2020
3

Molecular interactions of full-length and truncated GIP peptides with the GIP receptor - A comprehensive review.
Maria Buur Nordskov Gabe, Wijnand J C van der Velden, Florent Xavier Smit, Lærke Smidt Gasbjerg, Mette Marie Rosenkilde. Peptides 2020
7

Cardiovascular biology of the GIP receptor.
Amanda A Greenwell, Jadin J Chahade, John R Ussher. Peptides 2020
3

Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor.
Xiaoshan Min, Junming Yie, Jinghong Wang, Ben C Chung, Ching-Shin Huang, Haoda Xu, Jie Yang, Liying Deng, Joanne Lin, Qing Chen,[...]. MAbs 2020
2

Sexually dimorphic metabolic responses to exposure of a high fat diet during pregnancy, lactation and early adulthood in Gipr-/- mice.
Michael Kruse, Farnaz Keyhani-Nejad, Martin A Osterhoff, Andreas F H Pfeiffer. Peptides 2020
1


Retinol-binding protein 2 (RBP2) binds monoacylglycerols and modulates gut endocrine signaling and body weight.
Seung-Ah Lee, Kryscilla Jian Zhang Yang, Pierre-Jacques Brun, Josie A Silvaroli, Jason J Yuen, Igor Shmarakov, Hongfeng Jiang, Jun B Feranil, Xueting Li, Atreju I Lackey,[...]. Sci Adv 2020
3

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism.
Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill. Clin Med Insights Endocrinol Diabetes 2020
19

How May GIP Enhance the Therapeutic Efficacy of GLP-1?
Ricardo J Samms, Matthew P Coghlan, Kyle W Sloop. Trends Endocrinol Metab 2020
23

Identification and characterization of adipose surface epitopes.
Yasuhiro Onogi, Ahmed Elagamy Mohamed Mahmoud Khalil, Siegfried Ussar. Biochem J 2020
4

Reprint of: Recent Updates on Obesity Treatments: Available Drugs and Future Directions.
Nathalia R V Dragano, Johan Fernø, Carlos Diéguez, Miguel López, Edward Milbank. Neuroscience 2020
4


Recent Updates on Obesity Treatments: Available Drugs and Future Directions.
Nathalia R V Dragano, Johan Fernø, Carlos Diéguez, Miguel López, Edward Milbank. Neuroscience 2020
12

Insights into incretin-based therapies for treatment of diabetic dyslipidemia.
Kerstin Stemmer, Brian Finan, Richard D DiMarchi, Matthias H Tschöp, Timo D Müller. Adv Drug Deliv Rev 2020
6


Medium-chain triglyceride diet stimulates less GIP secretion and suppresses body weight and fat mass gain compared with long-chain triglyceride diet.
Yuki Murata, Norio Harada, Shunsuke Yamane, Kanako Iwasaki, Eri Ikeguchi, Yoshinori Kanemaru, Takanari Harada, Akiko Sankoda, Satoko Shimazu-Kuwahara, Erina Joo,[...]. Am J Physiol Endocrinol Metab 2019
3

Inhibition of GIP signaling extends lifespan without caloric restriction.
Manabu Hoizumi, Takehiro Sato, Tatsunori Shimizu, Shunsuke Kato, Katsushi Tsukiyama, Takuma Narita, Hiroki Fujita, Tsukasa Morii, Mariko Harada Sassa, Yutaka Seino,[...]. Biochem Biophys Res Commun 2019
4